Collaboration with MelliTech, Grenoble, France, on the specificity of monoclonal IC2
License & research collaboration with MelliTech, Grenoble, France, concerning the monoclonal autoantibody IC2 and the ZnT8-transporter in pancreatic beta-cells.
Pilot commercial productions of the monoclonal autoantibody IC2
R&D collaboration with The Danish State Serum Institute, Copenhagen, Denmark concerning pilot production of the beta-cell specific monoclonal autoantibody IC2. The pilot preparation has been tested in Paris and Copenhagen. The unique specificity of IC2 against the plasma membrane of insulin-producing beta-cells was confirmed. Possible outsourcing contract with the biotech company Exbio, Prague, for a […]
© 2021 ImmunoSigns. All Rights Reserved.
Powered by WordPress. Designed by 